Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2012 1
2013 4
2014 3
2015 3
2016 1
2017 5
2018 2
2020 6
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
Blondy T, d'Almeida SM, Briolay T, Tabiasco J, Meiller C, Chéné AL, Cellerin L, Deshayes S, Delneste Y, Fonteneau JF, Boisgerault N, Bennouna J, Grégoire M, Jean D, Blanquart C. Blondy T, et al. Among authors: boisgerault n. J Immunother Cancer. 2020 Jun;8(1):e000182. doi: 10.1136/jitc-2019-000182. J Immunother Cancer. 2020. PMID: 32581053 Free PMC article.
[The yellow fever vaccine as a new cancer treatment?].
Petithomme T, Grard M, Fonteneau JF, Boisgerault N. Petithomme T, et al. Among authors: boisgerault n. Med Sci (Paris). 2020 Dec;36(12):1216-1217. doi: 10.1051/medsci/2020236. Epub 2020 Dec 9. Med Sci (Paris). 2020. PMID: 33296641 Free article. French. No abstract available.
Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma.
Jean D, Delaunay T, Meiller C, Boisgerault N, Grard M, Caruso S, Blanquart C, Felley-Bosco E, Bennouna J, Tangy F, Grégoire M, Fonteneau JF. Jean D, et al. Among authors: boisgerault n. J Thorac Oncol. 2020 Jul;15(7):e113-e116. doi: 10.1016/j.jtho.2020.04.011. J Thorac Oncol. 2020. PMID: 32593448 No abstract available.
High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma.
Delaunay T, Nader J, Grard M, Farine I, Hedwig V, Foloppe J, Blondy T, Violland M, Pouliquen D, Grégoire M, Boisgerault N, Erbs P, Fonteneau JF. Delaunay T, et al. Among authors: boisgerault n. Mol Ther Oncolytics. 2020 Aug 25;18:573-578. doi: 10.1016/j.omto.2020.08.011. eCollection 2020 Sep 25. Mol Ther Oncolytics. 2020. PMID: 32995481 Free PMC article.
Oncolytic virotherapy for human malignant mesothelioma: recent advances.
Boisgerault N, Achard C, Delaunay T, Cellerin L, Tangy F, Grégoire M, Fonteneau JF. Boisgerault N, et al. Oncolytic Virother. 2015 Sep 10;4:133-40. doi: 10.2147/OV.S66091. eCollection 2015. Oncolytic Virother. 2015. PMID: 27512676 Free PMC article. Review.
Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus.
Delaunay T, Achard C, Boisgerault N, Grard M, Petithomme T, Chatelain C, Dutoit S, Blanquart C, Royer PJ, Minvielle S, Quetel L, Meiller C, Jean D, Fradin D, Bennouna J, Magnan A, Cellerin L, Tangy F, Grégoire M, Fonteneau JF. Delaunay T, et al. Among authors: boisgerault n. J Thorac Oncol. 2020 May;15(5):827-842. doi: 10.1016/j.jtho.2019.12.128. Epub 2020 Jan 13. J Thorac Oncol. 2020. PMID: 31945495 Free article.
Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence.
Kottke T, Evgin L, Shim KG, Rommelfanger D, Boisgerault N, Zaidi S, Diaz RM, Thompson J, Ilett E, Coffey M, Selby P, Pandha H, Harrington K, Melcher A, Vile R. Kottke T, et al. Among authors: boisgerault n. Cancer Immunol Res. 2017 Nov;5(11):1029-1045. doi: 10.1158/2326-6066.CIR-17-0175. Epub 2017 Oct 15. Cancer Immunol Res. 2017. PMID: 29038298 Free PMC article.
25 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page